Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2026136

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2026136

Obesity Intervention Devices Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The global obesity intervention devices market is progressing steadily as healthcare systems intensify efforts to address the growing burden of obesity and its associated complications. With obesity increasingly linked to chronic illnesses such as type 2 diabetes, cardiovascular diseases, and metabolic disorders, the need for effective treatment solutions has become more critical than ever. Medical devices designed for obesity intervention are gaining traction as viable alternatives to invasive surgical procedures. The market is anticipated to reach US$ 301 Mn in 2026 and further expand to US$ 381.2 Mn by 2033, registering a CAGR of 3.40% over the forecast period. The rising acceptance of device-based therapies and continuous technological innovation are expected to sustain market momentum.

Market Insights

Obesity intervention devices encompass a range of solutions aimed at facilitating weight loss through mechanisms such as limiting food intake, delaying gastric emptying, or modulating neural signals related to hunger. These devices are increasingly preferred due to their minimally invasive nature and reversibility compared to traditional bariatric surgeries. The market is evolving with a strong focus on patient-centric solutions that enhance comfort, safety, and treatment outcomes.

Growing awareness about the health risks associated with obesity, combined with the availability of advanced medical technologies, is encouraging more patients to opt for device-based interventions. Healthcare providers are also integrating these devices into broader weight management programs, combining them with dietary guidance and behavioral therapy to achieve long-term success. This integrated approach is strengthening the role of obesity intervention devices in modern healthcare systems.

Drivers

The increasing global prevalence of obesity is a primary factor driving the demand for intervention devices. Rapid urbanization, sedentary lifestyles, and unhealthy dietary patterns have significantly contributed to rising obesity rates across both developed and emerging economies. As traditional weight loss methods often yield limited success for severe obesity cases, the demand for effective medical solutions continues to rise.

Technological advancements are further accelerating market growth. Innovations such as non-surgical gastric balloons, implantable stimulation devices, and adjustable gastric systems are improving treatment outcomes while minimizing risks. These developments are making obesity intervention devices more accessible and acceptable to a wider patient population.

Another important driver is the growing emphasis on preventive healthcare. Governments and healthcare organizations are increasingly recognizing the long-term economic impact of obesity-related diseases and are promoting early intervention strategies. This has led to increased adoption of medical devices that support weight management and reduce the risk of associated complications.

Business Opportunity

The market offers considerable opportunities for growth, particularly through the development of next-generation devices that enhance patient experience and clinical effectiveness. Companies are investing heavily in research and development to introduce innovative solutions that are less invasive, more efficient, and easier to use.

Emerging economies present strong growth prospects due to improving healthcare infrastructure and rising awareness about obesity management. As disposable incomes increase and access to advanced medical treatments improves, the adoption of obesity intervention devices is expected to grow significantly in these regions.

Strategic partnerships between device manufacturers and healthcare providers are also creating new avenues for expansion. By offering integrated treatment solutions that combine medical devices with lifestyle interventions, companies can deliver more comprehensive care and improve patient outcomes.

Region Analysis

North America holds a leading position in the obesity intervention devices market, supported by a high prevalence of obesity, advanced healthcare systems, and strong adoption of innovative technologies. The presence of major market players and favorable reimbursement frameworks further strengthens the region's dominance.

Europe follows closely, with increasing awareness about obesity-related health issues and a growing preference for minimally invasive treatments. Government initiatives promoting healthy lifestyles and early intervention are contributing to market growth across the region.

Asia Pacific is emerging as a high-growth market, driven by rapid urbanization, changing dietary habits, and increasing healthcare investments. Countries such as China and India are witnessing a rise in obesity cases, creating significant demand for effective treatment solutions.

Latin America and the Middle East & Africa are gradually gaining traction, supported by improving healthcare access and growing awareness about obesity management. These regions are expected to offer new growth opportunities in the coming years.

Key Players

  • Medtronic plc
  • ReShape Lifesciences, Inc.
  • Cousin Surgery
  • A.M.I. GmbH
  • BAROnova, Inc.
  • Johnson & Johnson
  • Allurion Technologies, Inc.
  • Endalis Laboratoire
  • GI Dynamics
  • Boston Scientific
  • Abbvie Inc.
  • Spatz FGIA Inc

Segmentation

By Product

  • Gastric Banding
  • Gastric Space-Occupying Devices
  • Gastric Stimulation Systems
  • Gastric Emptying Systems
  • Miscellaneous

By End User

  • Hospitals & Clinics
  • Obesity Centres
  • Homecare Settings
  • Miscellaneous

By Geographic

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Obesity Intervention Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Obesity Intervention Devices Market Outlook, 2020-2033

  • 3.1. Global Obesity Intervention Devices Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 3.1.1. Gastric Banding
    • 3.1.2. Gastric Space-Occupying Devices
    • 3.1.3. Gastric Stimulation Systems
    • 3.1.4. Gastric Emptying Systems
    • 3.1.5. Miscellaneous
  • 3.2. Global Obesity Intervention Devices Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 3.2.1. Hospitals & Clinics
    • 3.2.2. Obesity Centres
    • 3.2.3. Homecare Settings
    • 3.2.4. Miscellaneous
  • 3.3. Global Obesity Intervention Devices Market Outlook, by Region, Value (US$ Mn), 2020-2033
    • 3.3.1. North America
    • 3.3.2. Europe
    • 3.3.3. Asia Pacific
    • 3.3.4. Latin America
    • 3.3.5. Middle East & Africa

4. North America Obesity Intervention Devices Market Outlook, 2020-2033

  • 4.1. North America Obesity Intervention Devices Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 4.1.1. Gastric Banding
    • 4.1.2. Gastric Space-Occupying Devices
    • 4.1.3. Gastric Stimulation Systems
    • 4.1.4. Gastric Emptying Systems
    • 4.1.5. Miscellaneous
  • 4.2. North America Obesity Intervention Devices Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 4.2.1. Hospitals & Clinics
    • 4.2.2. Obesity Centres
    • 4.2.3. Homecare Settings
    • 4.2.4. Miscellaneous
  • 4.3. North America Obesity Intervention Devices Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 4.3.1. U.S. Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 4.3.2. U.S. Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 4.3.3. Canada Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 4.3.4. Canada Obesity Intervention Devices Market Outlook, by End User, 2020-2033
  • 4.4. BPS Analysis/Market Attractiveness Analysis

5. Europe Obesity Intervention Devices Market Outlook, 2020-2033

  • 5.1. Europe Obesity Intervention Devices Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 5.1.1. Gastric Banding
    • 5.1.2. Gastric Space-Occupying Devices
    • 5.1.3. Gastric Stimulation Systems
    • 5.1.4. Gastric Emptying Systems
    • 5.1.5. Miscellaneous
  • 5.2. Europe Obesity Intervention Devices Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Obesity Centres
    • 5.2.3. Homecare Settings
    • 5.2.4. Miscellaneous
  • 5.3. Europe Obesity Intervention Devices Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 5.3.1. Germany Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 5.3.2. Germany Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 5.3.3. Italy Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 5.3.4. Italy Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 5.3.5. France Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 5.3.6. France Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 5.3.7. U.K. Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 5.3.8. U.K. Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 5.3.9. Spain Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 5.3.10. Spain Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 5.3.11. Russia Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 5.3.12. Russia Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 5.3.13. Rest of Europe Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 5.3.14. Rest of Europe Obesity Intervention Devices Market Outlook, by End User, 2020-2033
  • 5.4. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Obesity Intervention Devices Market Outlook, 2020-2033

  • 6.1. Asia Pacific Obesity Intervention Devices Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 6.1.1. Gastric Banding
    • 6.1.2. Gastric Space-Occupying Devices
    • 6.1.3. Gastric Stimulation Systems
    • 6.1.4. Gastric Emptying Systems
    • 6.1.5. Miscellaneous
  • 6.2. Asia Pacific Obesity Intervention Devices Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Obesity Centres
    • 6.2.3. Homecare Settings
    • 6.2.4. Miscellaneous
  • 6.3. Asia Pacific Obesity Intervention Devices Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 6.3.1. China Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 6.3.2. China Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 6.3.3. Japan Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 6.3.4. Japan Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 6.3.5. South Korea Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 6.3.6. South Korea Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 6.3.7. India Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 6.3.8. India Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 6.3.9. Southeast Asia Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 6.3.10. Southeast Asia Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 6.3.11. Rest of SAO Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 6.3.12. Rest of SAO Obesity Intervention Devices Market Outlook, by End User, 2020-2033
  • 6.4. BPS Analysis/Market Attractiveness Analysis

7. Latin America Obesity Intervention Devices Market Outlook, 2020-2033

  • 7.1. Latin America Obesity Intervention Devices Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 7.1.1. Gastric Banding
    • 7.1.2. Gastric Space-Occupying Devices
    • 7.1.3. Gastric Stimulation Systems
    • 7.1.4. Gastric Emptying Systems
    • 7.1.5. Miscellaneous
  • 7.2. Latin America Obesity Intervention Devices Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Obesity Centres
    • 7.2.3. Homecare Settings
    • 7.2.4. Miscellaneous
  • 7.3. Latin America Obesity Intervention Devices Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 7.3.1. Brazil Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 7.3.2. Brazil Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 7.3.3. Mexico Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 7.3.4. Mexico Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 7.3.5. Argentina Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 7.3.6. Argentina Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 7.3.7. Rest of LATAM Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 7.3.8. Rest of LATAM Obesity Intervention Devices Market Outlook, by End User, 2020-2033
  • 7.4. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Obesity Intervention Devices Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Obesity Intervention Devices Market Outlook, by Product, Value (US$ Mn), 2020-2033
    • 8.1.1. Gastric Banding
    • 8.1.2. Gastric Space-Occupying Devices
    • 8.1.3. Gastric Stimulation Systems
    • 8.1.4. Gastric Emptying Systems
    • 8.1.5. Miscellaneous
  • 8.2. Middle East & Africa Obesity Intervention Devices Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Obesity Centres
    • 8.2.3. Homecare Settings
    • 8.2.4. Miscellaneous
  • 8.3. Middle East & Africa Obesity Intervention Devices Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 8.3.1. GCC Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 8.3.2. GCC Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 8.3.3. South Africa Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 8.3.4. South Africa Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 8.3.5. Egypt Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 8.3.6. Egypt Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 8.3.7. Nigeria Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 8.3.8. Nigeria Obesity Intervention Devices Market Outlook, by End User, 2020-2033
    • 8.3.9. Rest of Middle East Obesity Intervention Devices Market Outlook, by Product, 2020-2033
    • 8.3.10. Rest of Middle East Obesity Intervention Devices Market Outlook, by End User, 2020-2033
  • 8.4. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Medtronic plc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. ReShape Lifesciences, Inc.
    • 9.4.3. Cousin Surgery
    • 9.4.4. A.M.I. GmbH
    • 9.4.5. BAROnova, Inc.
    • 9.4.6. Johnson & Johnson
    • 9.4.7. Allurion Technologies, Inc.
    • 9.4.8. Endalis Laboratoire
    • 9.4.9. GI Dynamics
    • 9.4.10. Boston Scientific

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!